Herbalife Nutrition Ltd vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Herbalife Nutrition Ltd trades at $13.76 (market cap $1.49B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $38.01 (market cap $63.57B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 42.7× Herbalife Nutrition Ltd's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.49% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| HLF | RELX | |
|---|---|---|
Market Cap | $1.49B | $63.57B |
Volume | 1,708,975 | 1,602,093 |
Sector | Consumer Staples | Industrials |
52-Week High | $19.96 | $46.80 |
52-Week Low | $7.75 | $27.73 |
Typical Hold Time | 43 Days | — |
Enterprise Value | $3.32B | $75.05B |
Dividend Yield | — | 2.49% |
Signals from Pluang's Aura AI — not financial advice
HLF trades at $14.19, up 4.26% today, with a bullish technical signal and strong analyst consensus. The stock shows attractive valuation with a P/E of 9.11 and P/S of 0.29, supported by a gross profit margin of 77.7%. Recent news includes a $250 million share repurchase program and a planned CEO transition in October 2026. Cash flow trends indicate improving operational cash generation, with 2026 projected net cash flow turning positive at $50 million.
The outlook for HLF is positive, with a consensus price target of $19.00 implying 34% upside. Risks include negative shareholder equity, high debt levels, and mixed quarterly earnings performance. Revenue stability and margin expansion efforts provide a foundation for growth, but investor caution is warranted due to ongoing leadership changes and competitive pressures in the wellness sector.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →